Digital Psychotherapeutics Market Report 2026

The digital psychotherapeutics market size has grown exponentially in recent years. It will grow from $2.4 billion in 2025 to $3.17 billion in 2026 at a compound annual growth rate (CAGR) of 32.2%. The growth in the historic period can be attributed to mental health stigma reduction, shortage of therapists, early teletherapy adoption, increasing anxiety prevalence, smartphone-based care models.

The digital psychotherapeutics market size is expected to see exponential growth in the next few years. It will grow to $8.23 billion in 2030 at a compound annual growth rate (CAGR) of 26.9%. The growth in the forecast period can be attributed to ai-assisted therapy platforms, employer mental health programs, clinical validation of digital therapeutics, vr-based exposure therapy growth, insurance reimbursement expansion. Major trends in the forecast period include increasing use of app-based mental health therapies, growing adoption of digital cbt platforms, expansion of remote psychological care models, rising demand for anxiety and stress management tools, integration of wearables for mental health monitoring.

The increasing incidence of mental health disorders is expected to drive the growth of the digital psychotherapeutics market in the coming years. Mental health disorders encompass a broad range of conditions that influence an individual’s thoughts, emotions, and behavior, often resulting in emotional distress and reduced ability to function in daily activities. The rise in these disorders is largely linked to heightened stress, societal pressures, and exposure to traumatic experiences, all of which increase the demand for effective therapeutic support. Digital psychotherapy enhances accessibility by offering flexible scheduling and removing the need for physical travel to therapy sessions. For instance, in November 2023, according to data released by NHS Digital, a UK-based government agency responsible for health and care statistics, nearly one in five children and young people aged 8 to 25 were identified as having a probable mental health disorder in 2023. Prevalence rates stood at 20.3% for ages 8 to 16, 23.3% for those aged 17 to 19, and 21.7% among young adults aged 20 to 25. Therefore, the growing incidence of mental health disorders is fueling the expansion of the digital psychotherapeutics market.

Major companies operating in the prescription digital therapeutics space are increasingly integrating software-as-a-medical-device solutions, including digital psychotherapeutic applications, to improve treatment accessibility, patient engagement, and clinical effectiveness. Digital psychotherapeutic applications are software-based medical tools that deliver structured, evidence-driven therapeutic interventions through mobile platforms, enabling features such as guided cognitive and emotional training, remote therapy access, and real-time patient support. For instance, in April 2024, Otsuka Pharmaceutical Co., Ltd., a Japan-based global healthcare company, received approval from the US Food and Drug Administration for Rejoyn, a prescription digital therapeutic developed to support adults with major depressive disorder when used alongside antidepressant medications. The solution features a six-week, app-based program combining cognitive-emotional training with brief therapeutic lessons, is accessible on both iOS and Android devices, and is supported by clinical validation from a large remote randomized trial. Rejoyn enhances treatment adherence, outcomes, and access to structured psychotherapy.

In July 2023, Big Health Inc., a US-based provider of non-pharmacological digital treatments for conditions such as insomnia and anxiety, acquired Limbix for an undisclosed amount. Through this acquisition, Big Health gained access to Limbix’s adolescent-focused digital therapeutic pipeline, including the evidence-supported SparkRx program for teenage depression. This strategic move strengthens Big Health’s position in youth mental health by expanding its treatment portfolio, operational scale, and market reach. Limbix Inc. is a US-based developer of digital therapeutics for adolescents and young adults experiencing depressive symptoms, recognized for its self-guided cognitive behavioral therapy-based mobile interventions and strong clinical research foundation.

Major companies operating in the digital psychotherapeutics market are AbleTo Inc., BetterHelp Inc., Ginger.io Inc., Meru Health Inc., Novartis International AG, Pear Therapeutics Inc., SilverCloud Health Limited, Spring Health Inc., Starling Minds Inc., SwissDT AG, Talkspace Inc., Woebot Health Inc., CBT Nuggets LLC, Quartet Health Inc., Neurotrack Technologies Inc., Limbix Health Inc., Happify Health LLC, Mindstrong Health Inc., Minddistrict B.V., Ieso Digital Health, Eleos Health, MDLIVE, Lyra Health.

North America was the largest region in the digital psychotherapeutics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital psychotherapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital psychotherapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs impact the digital psychotherapeutics market by increasing costs of imported VR devices, wearable sensors, and supporting hardware. North America and Europe are most affected due to high device adoption, while Asia-Pacific faces pricing barriers. These tariffs raise deployment costs. However, they encourage local device production and regional digital mental health innovation.

The digital psychotherapeutics market research report is one of a series of new reports that provides digital psychotherapeutics market statistics, including digital psychotherapeutics industry global market size, regional shares, competitors with a digital psychotherapeutics market share, detailed digital psychotherapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the digital psychotherapeutics industry. This digital psychotherapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Digital psychotherapeutics refers to the use of online or digital platforms and tools to deliver psychotherapeutic interventions and treatments through mobile applications, web-based platforms, or virtual reality solutions.

The main types of digital psychotherapeutics include mobile apps, online platforms, virtual reality, and wearable devices. Mobile apps are software applications developed for smartphones or tablets that provide a range of therapeutic functions and services to users. These solutions address indications such as phobias and anxiety disorders, psychotic disorders, and others, and are delivered through business models including direct-to-patient or consumer and business-to-business models. They are applied across prevention, management, and treatment use cases and are utilized by end users such as healthcare providers and payers.

The digital psychotherapeutics market consists of revenues earned by entities by providing services such as virtual counseling sessions, online therapy, and teletherapy services that assist in delivering mental health support and interventions remotely. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital psychotherapeutics market also includes sales of digital therapy devices, remote monitoring tools, interactive online programs, and computer-based cognitive behavioral therapy (CBT) platforms that help in mental health management. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.